U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Chronic Eosinophilic Leukemia with FIP1L1-PDGFRA

MedGen UID:
927323
•Concept ID:
C4289791
•
Neoplastic Process
Synonym: Chronic Eosinophilic Leukemia with FIP1L1::PDGFRA

Definition

Chronic eosinophilic leukemia characterized by the rearrangement of the PDGFRA gene, most often resulting in the formation of FIP1L1-PDGFRA fusion transcripts. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVChronic Eosinophilic Leukemia with FIP1L1-PDGFRA

Professional guidelines

PubMed

World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
Am J Hematol 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617. PMID: 31423623
Management of Hypereosinophilic Syndromes.
Roufosse F
Immunol Allergy Clin North Am 2015 Aug;35(3):561-75. doi: 10.1016/j.iac.2015.05.006. PMID: 26209900
FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.
Cools J
Verh K Acad Geneeskd Belg 2005;67(3):169-76. PMID: 16089297

Recent clinical studies

Etiology

Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M
Sci Rep 2021 Mar 18;11(1):6388. doi: 10.1038/s41598-021-85852-9. PMID: 33737704Free PMC Article
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
Am J Hematol 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617. PMID: 31423623
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P
Clin Rev Allergy Immunol 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7. PMID: 26475367
Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
Valent P
Blood Rev 2009 Jul;23(4):157-65. Epub 2009 Feb 25 doi: 10.1016/j.blre.2009.01.001. PMID: 19246139
Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias.
Vandenberghe P, Wlodarska I, Michaux L, Zachée P, Boogaerts M, Vanstraelen D, Herregods MC, Van Hoof A, Selleslag D, Roufosse F, Maerevoet M, Verhoef G, Cools J, Gilliland DG, Hagemeijer A, Marynen P
Leukemia 2004 Apr;18(4):734-42. doi: 10.1038/sj.leu.2403313. PMID: 14973504

Diagnosis

World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
Am J Hematol 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617. PMID: 31423623
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P
Clin Rev Allergy Immunol 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7. PMID: 26475367
Management of Hypereosinophilic Syndromes.
Roufosse F
Immunol Allergy Clin North Am 2015 Aug;35(3):561-75. doi: 10.1016/j.iac.2015.05.006. PMID: 26209900
FIP1L1/PDGFR alpha-associated systemic mastocytosis.
Yamada Y, Cancelas JA
Int Arch Allergy Immunol 2010;152 Suppl 1(Suppl 1):101-5. Epub 2010 Jun 4 doi: 10.1159/000312134. PMID: 20523072Free PMC Article
The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia.
Cools J, Stover EH, Wlodarska I, Marynen P, Gilliland DG
Curr Opin Hematol 2004 Jan;11(1):51-7. doi: 10.1097/00062752-200401000-00008. PMID: 14676627

Therapy

S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells.
Lee JS, Lee NR, Kashif A, Yang SJ, Nam AR, Song IC, Gong SJ, Hong MH, Kim G, Seok PR, Lee MS, Sung KH, Kim IS
Front Immunol 2020;11:1258. Epub 2020 Aug 6 doi: 10.3389/fimmu.2020.01258. PMID: 32903598Free PMC Article
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
Am J Hematol 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617. PMID: 31423623
Management of Hypereosinophilic Syndromes.
Roufosse F
Immunol Allergy Clin North Am 2015 Aug;35(3):561-75. doi: 10.1016/j.iac.2015.05.006. PMID: 26209900
Eosinophilia in mast cell disease.
Kovalszki A, Weller PF
Immunol Allergy Clin North Am 2014 May;34(2):357-64. Epub 2014 Mar 13 doi: 10.1016/j.iac.2014.01.013. PMID: 24745679Free PMC Article
FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.
Cools J
Verh K Acad Geneeskd Belg 2005;67(3):169-76. PMID: 16089297

Prognosis

Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M
Sci Rep 2021 Mar 18;11(1):6388. doi: 10.1038/s41598-021-85852-9. PMID: 33737704Free PMC Article
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W, Gotlib J
Am J Hematol 2019 Oct;94(10):1149-1167. doi: 10.1002/ajh.25617. PMID: 31423623
Hypereosinophilic Syndrome.
Curtis C, Ogbogu P
Clin Rev Allergy Immunol 2016 Apr;50(2):240-51. doi: 10.1007/s12016-015-8506-7. PMID: 26475367
Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders.
Gotlib J, Akin C
Semin Hematol 2012 Apr;49(2):128-37. doi: 10.1053/j.seminhematol.2012.01.007. PMID: 22449623
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.
Gotlib J, Cools J, Malone JM 3rd, Schrier SL, Gilliland DG, Coutré SE
Blood 2004 Apr 15;103(8):2879-91. Epub 2003 Nov 20 doi: 10.1182/blood-2003-06-1824. PMID: 15070659

Clinical prediction guides

Venous thrombosis and predictors of relapse in eosinophil-related diseases.
Réau V, Vallée A, Terrier B, Plessier A, Abisror N, Ackermann F, Benainous R, Bohelay G, Chabi-Charvillat ML, Cornec D, Desbois AC, Faguer S, Freymond N, Gaillet A, Hamidou M, Killian M, Le Jeune S, Marchetti A, Meyer G, Osorio-Perez F, Panel K, Rautou PE, Rohmer J, Simon N, Tcherakian C, Vasse M, Zuelgaray E, Lefevre G, Kahn JE, Groh M
Sci Rep 2021 Mar 18;11(1):6388. doi: 10.1038/s41598-021-85852-9. PMID: 33737704Free PMC Article
Generalized Eruptive Histiocytosis Associated With FIP1L1-PDGFRA-Positive Chronic Eosinophilic Leukemia.
Ziegler B, Peitsch WK, Reiter A, Marx A, Goerdt S, Géraud C
JAMA Dermatol 2015 Jul;151(7):766-9. doi: 10.1001/jamadermatol.2015.0154. PMID: 25923837
F604S exchange in FIP1L1-PDGFRA enhances FIP1L1-PDGFRA protein stability via SHP-2 and SRC: a novel mode of kinase inhibitor resistance.
Gorantla SP, Zirlik K, Reiter A, Yu C, Illert AL, Von Bubnoff N, Duyster J
Leukemia 2015 Aug;29(8):1763-70. Epub 2015 Mar 12 doi: 10.1038/leu.2015.70. PMID: 25761934
Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant.
Lierman E, Folens C, Stover EH, Mentens N, Van Miegroet H, Scheers W, Boogaerts M, Vandenberghe P, Marynen P, Cools J
Blood 2006 Aug 15;108(4):1374-6. Epub 2006 Apr 27 doi: 10.1182/blood-2006-02-004457. PMID: 16645167Free PMC Article
The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management.
Gotlib J, Cools J, Malone JM 3rd, Schrier SL, Gilliland DG, Coutré SE
Blood 2004 Apr 15;103(8):2879-91. Epub 2003 Nov 20 doi: 10.1182/blood-2003-06-1824. PMID: 15070659

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...